AR
adhdresearch.news

ADHD Research News

Medical literature is actively hostile to ADHD brains. Dense, jargon-heavy, wall-of-text PDFs — the worst possible format for the people who need it most.

We built this website as an answer to the overwhelm. We work through the papers, pull out what matters, and tell you what you can actually do with it.

This website is designed for focus, too — try and see it for yourself.

Expert insights from
Academic blogs

We're building the most current ADHD resource anywhere.

The feed

New research comes in

Studies from PubMed, announcements from the FDA, insights from experts. We're watching all of it, continuously.

The work

We distill it into what matters

Each piece becomes a summary with one clear takeaway: what you can actually do with this information.

The result

The knowledge base updates

Every relevant topic page absorbs the new finding. Our page on ADHD paralysis today includes research that didn't exist last month.

repeat, forever

Knowledge stays current

When you read our page on ADHD paralysis, you're reading everything we know right now — including the study that came out today.

February 2026

View full month →
May 22, 2026
PubMed

ADHD Carries a 6x Higher Self-Harm Risk — Young Adults and Women Face the Greatest Danger

A 16-year Hong Kong cohort of over 1.2 million people found that individuals with ADHD had a hazard ratio of 6.09 for incident self-harm compared to controls without mental disorders. Risk was highest in those aged 24 and under, and females with ADHD showed disproportionately elevated risk. This is a large, well-powered population study — the signal is hard to dismiss.

What you can do

If you have ADHD — especially if you're a young adult or a woman — ask your clinician to include self-harm screening and a basic safety plan as part of routine care, not just crisis care.

May 22, 2026
PubMed

Low Self-Belief Isn't a Personal Failing — It's a Near-Universal Pattern Across Neurodivergent Conditions

A two-wave observational study of over 2,000 people across seven neurodivergent conditions — including ADHD, autism, dyslexia, and DCD — found a consistent pattern: elevated negative self-beliefs and reduced positive self-beliefs across the board. This suggests the self-doubt many people with ADHD experience is a shared structural feature of neurodivergence, not an individual character flaw. The study also found that self-identifying as neurodivergent predicted personality dimensions beyond what a formal diagnosis alone captured.

What you can do

If you have ADHD and struggle with chronic self-doubt, recognize it as a documented pattern common to neurodivergent people — then seek support (therapy, coaching, peer community) that specifically targets negative self-beliefs rather than treating it as incidental.

May 22, 2026
PubMed

Stimulants Reduce Semen Volume by ~8% — But Sperm Count, Motility, and Morphology Are Unaffected

A matched cohort study of 1,164 reproductive-age men with ADHD found that active stimulant use was associated with an 8.4% lower semen volume compared to stimulant-unexposed men with ADHD. However, every other semen parameter — count, motility, morphology — showed no significant difference. The authors conclude stimulant use is unlikely to meaningfully impair fertility.

What you can do

If you're trying to conceive and taking stimulants, the evidence so far is reassuring on actual sperm quality — but raise the semen volume finding with your doctor if you're undergoing fertility evaluation.

May 22, 2026
PubMed

Air Pollution (PM2.5, PM10, NO2) Is Linked to Higher ADHD Risk in Children — But the Effect Is Modest and Not Proven Causal

A meta-analysis found that childhood exposure to fine particulate matter (PM2.5, PM10) and nitrogen dioxide (NO2) was associated with meaningfully increased ADHD risk — ORs of 1.32, 1.47, and 1.11 respectively. Noise exposure showed a statistically significant but very small association (OR 1.03). These are observational findings; causation hasn't been established, and some results were inconsistent across models.

What you can do

If you're choosing where to raise kids or how to reduce their environmental exposures, traffic-related air pollution is a legitimate factor to weigh — not a proven cause, but a consistent signal across studies.

May 22, 2026
PubMed

After 53 Trials of Novel ADHD Drugs, Only One New Agent Clears the Evidence Bar — and It's Not Approved Yet

A systematic review of 53 RCTs testing novel or off-label ADHD medications found that only centanafadine (in adults) had at least two positive trials with no negative ones. The only promising candidate for children, dasotraline, had its development programme shut down in 2020. The pipeline is thinner than the hype suggests.

What you can do

If current medications aren't working for you, centanafadine is the one agent worth watching — but it's still unapproved, so the honest near-term move is working with a prescriber to systematically trial existing options before waiting on pipeline drugs.